Fiorella Guadagni
Overview
Explore the profile of Fiorella Guadagni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
2322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAngeli F, Granata G, Romano I, Distefano A, Lo Furno D, Spila A, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39409022
Curcumin (Cur), the primary curcuminoid found in L., has garnered significant attention for its potential anti-inflammatory and antibacterial properties. However, its hydrophobic nature significantly limits its bioavailability. Additionally, adipose-derived stem...
2.
Leo M, DAngeli F, Genovese C, Spila A, Miele C, Ramadan D, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273680
Oral health is essential for both overall health and quality of life. The mouth is a window into the body's health, and nutrition can strongly impact the state of general...
3.
Condoluci C, Palmirotta R, Lawrence J, Smith K, Casini A, Di Girolamo G, et al.
Discov Med
. 2024 May;
36(184):913-922.
PMID: 38798251
Background: Down syndrome, or Trisomy 21, is the leading genetic cause of cognitive disability in children and is associated with a high risk of several comorbidities, particularly congenital heart defects,...
4.
Mencattini A, Daprati E, Della-Morte D, Guadagni F, Sangiuolo F, Martinelli E
Front Artif Intell
. 2024 May;
7:1385871.
PMID: 38708094
No abstract available.
5.
Nanni U, Ferroni P, Riondino S, Spila A, Valente M, Del Monte G, et al.
Cancer Genomics Proteomics
. 2023 Apr;
20(3):211-221.
PMID: 37093689
The growing demand for personalized medicine we are currently witnessing has given rise to more in-depth research in the field of biomarker discovery and, thus, in biological banks that hold...
6.
Ferroni P, Palmirotta R, Egeo G, Aurilia C, Valente M, Spila A, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430258
White matter hyperintensities (WMHs) in migraine could be related to inflammatory and antioxidant events. The aim of this study is to verify whether migraine patients with WMHs carry a genetic...
7.
Russo V, Lallo E, Munnia A, Spedicato M, Messerini L, DAurizio R, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36011003
Tailored treatments for metastatic colorectal cancer (mCRC) have not yet completely evolved due to the variety in response to drugs. Therefore, artificial intelligence has been recently used to develop prognostic...
8.
Genovese C, Garozzo A, DAngeli F, Malfa G, Bellia F, Tomasello B, et al.
Cells
. 2022 May;
11(10).
PMID: 35626733
Background: Breast cancer (BC) is the leading cause of death worldwide. The severity of BC strictly depends on the molecular subtype. The less aggressive hormone-positive subtype is treated with adjuvant...
9.
Imarisio A, Pilotto A, Garrafa E, Conforti F, Masciocchi S, Turrone R, et al.
Neurodegener Dis
. 2022 Mar;
21(5-6):109-116.
PMID: 35287127
Introduction: Previous studies reported increased plasma levels of cystatin C (Cys-C) in Parkinson's disease (PD) and claimed for a possible association with disease severity and progression. The aim of this...
10.
Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Galvano A, Del Re M, et al.
Crit Rev Oncol Hematol
. 2021 Dec;
169:103567.
PMID: 34896250
The development of innovative technologies and the advances in the genetics and genomics, have offered new opportunities for personalized treatment in oncology. Although the selection of the patient based on...